Federated Hermes, Inc. Guardant Health, Inc. Transaction History

Federated Hermes, Inc.

$50.2 Billion
Q2 2025

A detailed history of Federated Hermes, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,465,438 shares of GH stock, worth $95.7 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,465,438

Previous 850,009 72.4%

Holding current value

$95.7 Million

Previous $36.2 Million 110.61%

% of portfolio

0.15%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$37.05 - $52.04 $22.8 Million - $32 Million	615,429 Added 72.4%	1,465,438 $76.3 Million
Q1 2025 May 08, 2025	SELL	$31.77 - $49.94 $3.58 Million - $5.63 Million	-112,713 Reduced 11.71%	850,009 $36.2 Million
Q4 2024 Feb 13, 2025	BUY	$20.2 - $38.11 $2 Million - $3.78 Million	99,072 Added 11.47%	962,722 $29.4 Million
Q3 2024 Nov 13, 2024	BUY	$22.3 - $36.29 $34,565 - $56,249	1,550 Added 0.18%	863,650 $19.8 Million
Q2 2024 Aug 08, 2024	SELL	$16.07 - $31.84 $719,936 - $1.43 Million	-44,800 Reduced 4.94%	862,100 $24.9 Million
Q1 2024 May 14, 2024	SELL	$17.13 - $26.91 $5,139 - $8,073	-300 Reduced 0.03%	906,900 $18.7 Million
Q4 2023 Jan 31, 2024	SELL	$21.58 - $29.5 $4.37 Million - $5.97 Million	-202,300 Reduced 18.23%	907,200 $24.5 Million
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $5.17 Million - $8.01 Million	200,500 Added 22.06%	1,109,500 $32.9 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $6.28 Million - $11.4 Million	300,000 Added 49.26%	909,000 $32.5 Million
Q1 2023 May 08, 2023	BUY	$22.92 - $33.76 $2.61 Million - $3.85 Million	113,918 Added 23.01%	609,000 $14.3 Million
Q4 2022 Feb 13, 2023	BUY	$25.44 - $59.78 $11.3 Million - $26.6 Million	444,482 Added 878.42%	495,082 $13.5 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $436 - $610	-10 Reduced 0.02%	50,600 $2.72 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $1.06 Million - $2.84 Million	-36,690 Reduced 42.03%	50,610 $2.04 Million
Q1 2022 May 13, 2022	SELL	$48.25 - $100.49 $612,775 - $1.28 Million	-12,700 Reduced 12.7%	87,300 $5.78 Million
Q2 2020 Aug 13, 2020	BUY	$60.49 - $97.5 $6.05 Million - $9.75 Million	100,000 New	100,000 $8.11 Million
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $3.69 Million - $5.14 Million	-62,099 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $3.53 Million - $6.22 Million	-56,401 Reduced 47.6%	62,099 $3.96 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $1.6 Million - $2.28 Million	25,000 Added 26.74%	118,500 $10.2 Million
Q1 2019 May 10, 2019	SELL	$34.3 - $97.98 $1.08 Million - $3.09 Million	-31,500 Reduced 25.2%	93,500 $7.17 Million
Q4 2018 Feb 13, 2019	BUY	$29.2 - $46.1 $3.65 Million - $5.76 Million	125,000 New	125,000 $4.7 Million

Others Institutions Holding GH

# of Institutions

416

Shares Held

127M

Call Options Held

1.51M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $6.68B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Guardant Health, Inc. Transaction History